ORIGINAL RESEARCH
Published on 13 Jul 2026
Predictors for the severity of acute aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorders: a prospective cohort study
doi 10.3389/fimmu.2026.1714655
- 1,237 views
- Frontiers in Immunology
- Multiple Sclerosis and Neuroimmunology
- Research Topics
- Advances and Challenges in Neuromyelitis Optica: Bridging the Gap in Diagnosis and Treatment
Advances and Challenges in Neuromyelitis Optica: Bridging the Gap in Diagnosis and Treatment
2,883
Total downloads
16k
Total views and downloads
Articles
CASE REPORT
Published on 21 May 2026
Satralizumab in the management of aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder during pregnancy: a case report
doi 10.3389/fimmu.2026.1833243
- 1,434 views
ORIGINAL RESEARCH
Published on 04 May 2026
Bile acid metabolomics reveals distinct immunometabolic niches and enables accurate diagnosis of AQP4-IgG–seronegative NMOSD
doi 10.3389/fimmu.2026.1776159
- 1,204 views
REVIEW
Published on 15 Apr 2026
Global landscape of neuromyelitis optica spectrum disorder clinical trials: trends in therapies, geography, and outcomes
doi 10.3389/fimmu.2026.1695727
- 2,383 views
ORIGINAL RESEARCH
Published on 13 Mar 2026
Novel B-Cell targeting therapy with subcutaneous ofatumumab in AQP4-IgG-seronegative Neuromyelitis Optica Spectrum Disorders: efficacy and personalized dosing
doi 10.3389/fimmu.2026.1760491
- 1,625 views
CASE REPORT
Published on 11 Mar 2026
Syncope in AQP4-IgG-positive neuromyelitis optica spectrum disorder: a case series and literature review
doi 10.3389/fnins.2026.1722763
- 1,611 views
ORIGINAL RESEARCH
Published on 10 Mar 2026
Distinct macular structural and microvascular alterations differentiate neuromyelitis optica spectrum disorder from myelin oligodendrocyte glycoprotein antibody–associated disease in optic neuritis
doi 10.3389/fimmu.2026.1759144
- 1,298 views
ORIGINAL RESEARCH
Published on 12 Jan 2026
Outcomes and predictors of relapse and severe pneumonia in Chinese patients with AQP4-IgG-positive neuromyelitis optica spectrum disorder receiving inebilizumab: a prospective cohort study
doi 10.3389/fimmu.2025.1718896
- 2,169 views
- 1 citation
